Four children with postnatally diagnosed mosaic trisomy 12: Clinical features, literature review, and current diagnostic capabilities of genetic testing. Issue 4 (8th January 2020)

• Record Type: Journal Article
• Authors: Hu, Jie; Ou, Zhishuo; Surti, Urvashi; Kochmar, Sally; Hoffner, Lori; Madan‐Khetarpal, Suneeta; Arnold, Georgianne L.; Walsh, Leslie; Acquaro, Roxanne; Sebastian, Jessica; Yatsenko, Svetlana A.
• Is Part Of: American journal of medical genetics. Volume 182:Issue 4(2020)
• Page Start: 813
• Page End: 822
• Publication Date: 2020-01-08
• Subjects: aCGH -- hand and foot anomalies -- heart defect -- mosaicism -- trisomy 12; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.61482
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: Children or adults with mosaic trisomy 12 diagnosed postnatally are extremely rare. Only a small number of patients with this mosaicism have been reported in the literature. The clinical manifestation of mosaic trisomy 12 is variable, ranging from mild developmental delay to severe congenital anomaly and neonatal death. The trisomy 12 cells are not usually able to be detected by phytohemagglutinin stimulated peripheral blood chromosome analysis. The variability of phenotypes and the limited number of patients with this anomaly pose a challenge to predict the clinical outcomes. In this study, we present the phenotypes and laboratory findings in four patients and review the 11 previously reported patients with mosaic trisomy 12 diagnosed postnatally, as well as 11 patients with mosaic trisomy 12 diagnosed prenatally. The findings of this study provide useful information for laboratory diagnosis and clinical management of these patients.